We are pleased to share that Dr. Samer Kazziha has been appointed as the Chief of Cardiovascular Services for Henry Ford Macomb beginning September 15, 2018. In this new role, Dr. Kazziha will be leading strategic initiatives to advance the growth of the HFHS Cardiovascular Service Line in our market and facilitate the contin the destination site for cardiovascular care in this region. He will be overseeing program development, continuous quality improvement and clinical efficiency in the service line. Dr. Kazziha will represent the market on the system-wide Cardiovascular Service Line team as part of the new HFHS Strategic Plan. He will be leading extensive community outreach and education efforts and assist with associated marketing strategies. Dr. Kazziha will in addition, be participating in resident, Medical Staff and clinical staff educational initiatives in order to advance program quality. He will be responsible for developing collaboratives teams to provide best practice integrated care in all aspects of cardiovascular services.
Dr. Kazziha joins us with extensive experience. He completed his residency and cardiology fellowship at the Medical College of Virginia Hospitals and completed an interventional cardiology fellowship at William Beaumont Hospital and an interventional vascular fellowship at Cleveland Clinic. While in private practice in southeastern Michigan as an interventional cardiologist, he has held multiple leadership roles including Co-Director of Cardiac Catheterization Lab at St. John Hospital, Medical Director of Cardiovascular Services at Mt. Clemens Regional Medical Center and most recently Executive Director of Cardiovascular Services at Ascension Crittenten Hospital. He has led community educational campaigns to promote awareness of cardiovascular health; served as Program Director for an Interventional Cardiology Fellowship and conducted multiple educational programs for Medical Staff. Dr. Kazziha has a keen interest in innovation and research and has participated in multiple clinical investigational studies as the primary investigator.
We are very excited to engage Dr. Kazziha in this new strategic role that will help us to advance our vision for excellence and distinction in cardiovascular care. Please join us in welcoming Dr. Kazziha to our team!
Barbara Rossmann, President and CEO Joanna Pease, DO, CMO and Vice President Clinical Operations
